Organization Overview
Alternative names
autologous muscle derived stem cells (2 trials)
bifidobacterium infantis (1 trial)
cefuroxime (zinacef) (1 trial)
Acute Lung Injury (Phase 2)
Appendicitis (Phase 2)
Bacteremia (Phase 4)
Bone Demineralization, Pathologic (Phase 4)
Catheter-Related Infections (Phase 4)
Central Nervous System Neoplasms (Phase 2)
Chronic Disease (Phase 2)
Clostridium Infections (Phase 4)
Colorectal Neoplasms (Phase 1)
Communicable Diseases (Phase 4)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Coronavirus Infections (Phase 2)
Cystitis (Phase 2)
Cystitis, Interstitial (Phase 2)
Dacryocystitis (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Enuresis (Phase 2)
Fatty Liver (Phase 2)
Fibrosis (Phase 2)
Glioblastoma (Phase 2)
Heart Arrest (Phase 2)
Heart Diseases (Phase 2)
Heart Valve Diseases (Phase 2)
Hypertension (Phase 4)
Infections (Phase 4)
Influenza, Human (Phase 3)
Ischemia (Phase 2)
Lacerations (Phase 4)
Lacrimal Apparatus Diseases (Phase 4)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 2)
Lower Urinary Tract Symptoms (Phase 2)
Myocardial Ischemia (Phase 2)
Nervous System Neoplasms (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Pain, Postoperative (Phase 4)
Pelvic Pain (Phase 2)
Prostatitis (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Syndrome (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urinary Bladder, Overactive (Phase 4)
Urinary Bladder, Underactive (Phase 1)
Urinary Incontinence (Phase 4)
Urinary Incontinence, Stress (Phase 2)
Urinary Retention (Phase 1)
Urinary Tract Infections (Phase 4)
Urination Disorders (Phase 2)
Urological Manifestations (Phase 2)
Urologic Diseases (Phase 2)
Vulvodynia (Phase 2)